Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. MEDICLIN AG
  6. News
  7. Summary
    MED   DE0006595101

MEDICLIN AG

(MED)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

PRESS RELEASE : MediClin AG: Dr. Joachim Ramming becomes the new CEO of MEDICLIN

06/11/2021 | 06:43am EDT
DGAP-News: MediClin AG / Key word(s): Personnel 
MediClin AG: Dr. Joachim Ramming becomes the new CEO of MEDICLIN 
2021-06-11 / 12:41 
The issuer is solely responsible for the content of this announcement. 
=---------------------------------------------------------------------------------------------------------------------- 
Dr. Joachim Ramming becomes the new CEO of MEDICLIN 
In today's meeting, the Supervisory Board of MEDICLIN Aktiengesellschaft (MEDICLIN) has appointed Dr. Joachim Ramming 
as member of the Management Board of MEDICLIN and as Chairman of the Board. The PhD economist and health economist will 
succeed Volker Hippler on August 1, 2021, who is resigning his mandate as CEO and board member of the Company by mutual 
agreement with the Supervisory Board on June 30, 2021. 
"We would like to thank Mr. Hippler for his commitment and the work he has done over the past five years and wish him 
all the best for his professional and private future. At the same time, we are pleased to have won with Dr. Joachim 
Ramming a leader with industry experience. Together with his colleagues of the Management Board, he will successfully 
drive the development of MEDICLIN further with strategic impulses", said Dr. Jan Liersch, Chairman of the MEDICLIN 
Supervisory Board. 
For around 23 years, Dr. Joachim Ramming is active in the healthcare sector. He started his clinical career in 1998 
immediately after studying economics as a trainee at RHÖN-KLINIKUM AG, where he learned how to manage a hospital from 
scratch. Around 20 years of management experience in clinic and hospital management followed, including eight years as 
managing director of hospitals at Sana Kliniken AG. From July 2015 until his appointment to the Management Board of 
MEDICLIN, Dr. Joachim Ramming works as managing director or regional managing director for the Asklepios Group, since 
March 2017 as regional managing director of Asklepios Kliniken Bayern. He is a member of the board of directors of the 
Association of Private Hospitals in Bavaria. V. (VPKA). 
"I am very much looking forward to bring my experience to MEDICLIN and to start to sustainably develop the Company 
together with my two board colleagues, Tino Fritz and Dr. York Dhein,", said Dr. Joachim Ramming after his appointment 
and added: "Every crisis is also an opportunity. We must join forces to overcome the consequences of the corona 
pandemic for MEDICLIN and lead the company into the future. The entire team of the Management Board of MEDICLIN 
therefore sees the strategic and organizational development as the most urgent task for the coming months." 
Dr. Joachim Ramming is a proven expert in the acute sector, he also knows the rehabilitation and medical care center 
business very well, and will also promote the consistent use of the synergies that arise from the cooperation within 
the Asklepios Group. 
About MEDICLIN Aktiengesellschaft (Ticker: MED; WKN: 659 510) 
MEDICLIN includes 35 clinics, seven care facilities and ten medical care centers. The Group has around 8,350 beds / 
care places and employs around 10,300 people. In a strong network, MEDICLIN offers the patient integrative care from 
the first visit to the doctor through the operation and subsequent rehabilitation to outpatient aftercare. Doctors, 
therapists and nurses work together in a carefully coordinated manner. MEDICLIN designs the care and support of people 
in need of care according to their individual needs and personal needs. 
MEDICLIN   a Company of the Asklepios Group. 
=---------------------------------------------------------------------------------------------------------------------- 
2021-06-11 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. 
The issuer is solely responsible for the content of this announcement. 
The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. 
Archive at www.dgap.de 
=---------------------------------------------------------------------------------------------------------------------- 
Language:     English 
Company:      MediClin AG 
              Okenstraße 27 
              77652 Offenburg 
              Germany 
Phone:        +49 (0)781 488-326 
Fax:          +49 (0)781 488-184 
E-mail:       alexandra.muehr@mediclin.de 
Internet:     www.mediclin.de 
ISIN:         DE0006595101 
WKN:          659510 
Listed:       Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, 
              Hamburg, Munich, Stuttgart, Tradegate Exchange 
EQS News ID:  1207118 
 
End of News   DGAP News Service 
=------------ 

1207118 2021-06-11

 
Image link: 
https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1207118&application_name=news 
 

(END) Dow Jones Newswires

June 11, 2021 06:42 ET (10:42 GMT)

Stocks mentioned in the article
ChangeLast1st jan.
DJ INDUSTRIAL 0.04% 34479.6 Delayed Quote.12.61%
MEDICLIN AG 0.00% 4.2 Delayed Quote.8.25%
All news about MEDICLIN AG
06/11PRESS RELEASEá : MediClin AG: Dr. Joachim Ramming becomes the new CEO of MEDICLI..
DJ
06/11MEDICLIN AG : Dr. Joachim Ramming becomes the new CEO of MEDICLIN
EQ
05/28PRESS RELEASEá : MEDICLIN focuses on patient safety and innovative concepts in r..
DJ
05/28MEDICLINá : focuses on patient safety and innovative concepts in rehabilitation
EQ
05/03PRESS RELEASEá : MediClin AG: The effects of the coronavirus pandemic are burden..
DJ
05/03MEDICLIN AG : The effects of the coronavirus pandemic are burdening the business..
EQ
03/26MEDICLIN AG : Massive loss of earnings due to corona pandemic - outlook 2021 aff..
EQ
03/26PRESS RELEASEá : MediClin AG: Massive loss of earnings due to corona pandemic - ..
DJ
02/26PRESS RELEASEá : MediClin AG: MEDICLIN has achieved the revised targets for 2020
DJ
02/26MEDICLIN AG : MEDICLIN has achieved the revised targets for 2020
EQ
More news
Financials
Sales 2021 660 M 799 M 799 M
Net income 2021 -9,33 M -11,3 M -11,3 M
Net Debt 2021 - - -
P/E ratio 2021 -
Yield 2021 -
Capitalization 200 M 241 M 242 M
Capi. / Sales 2021 0,30x
Capi. / Sales 2022 0,28x
Nbr of Employees 7 525
Free-Float 12,3%
Chart MEDICLIN AG
Duration : Period :
MEDICLIN AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MEDICLIN AG
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 1
Average target price 5,55 €
Last Close Price 4,20 €
Spread / Highest target 32,1%
Spread / Average Target 32,1%
Spread / Lowest Target 32,1%
Managers and Directors
NameTitle
Volker Hippler Chairman-Management Board & CEO
Tino Marco Fritz Chief Financial Officer
Jan Liersch Chairman-Supervisory Board
J÷rg St÷rmer Head-Purchasing & Medical Technology
York Dhein Chief Operating Officer
Sector and Competitors
1st jan.Capitalization (M$)
MEDICLIN AG8.25%241
AIER EYE HOSPITAL GROUP CO., LTD.14.69%55 324
FRESENIUS SE & CO. KGAA19.60%30 521
TOPCHOICE MEDICAL CORPORATION39.78%19 369
IHH HEALTHCARE-0.36%11 703
BANGKOK DUSIT MEDICAL SERVICES0.00%11 654